Man who let snakes bite him 200 times spurs new antivenom hope
AFP | Paris
Tim Friede was feeling particularly down on the day after the September 11 attacks, so he went to his basement and let two of the world's deadliest snakes bite him.
Four days later, he woke up from a coma.
"I know what it feels like to die from snakebite," Friede told AFP via video call from his home in the small US town of Two Rivers, Wisconsin.
This experience might put most people off snakes entirely, but Friede simply vowed to be m o r e careful next time.
From 2000 to 2018, he allowed himself to be bitten by snakes more than 200 times. He also injected himself with their venom over 650 times.
Friede endured this pain because he wanted to achieve total immunity to venom, a practice called mithridatism which should not be tried at home.
After a couple of years, Friede started to believe he could be the basis for a better kind of antivenom.
The former truck mechanic, who does not have a university degree, long struggled to be taken seriously by scientists. B u t l a s t month, a study pub - lished in the prest i g i o u s Cell journal showed that antibodies from his blood protect against a range of snake venom. The researchers now hope Friede's hyper-immunity could even lead to the development of a universal antivenom. This would fill a major need, because currently most antivenoms only cover one or a few of the world's 600 venomous snakes.
Up to 138,000 people are killed by snakebites a year, while 400,000 suffer amputations or other disabilities, according to the World Health Organization.
These figures are believed to be vastly underestimated because snakebite victims typically live in poorer, remote areas.
'Pain every time'
Friede's first bite was from a harmless garter snake when he was five years old.
"I was afraid, I cried, I ran away," said Friede, now 57.
Then he started bringing snakes home and hiding them in pickle jars. His mother sought counselling, but his interest in snakes persisted.
Things escalated after Friede attended a class that taught him how to "milk" snakes for their venom.
How antivenom is made has changed little over the last 125 years.
Small doses of snake venom are injected into animals such as horses, which produce antibodies that can be extracted and used as antivenom.
However this antivenom usually only works for bites from that particular species of snake -- and it includes other antibodies from horse that can cause serious side-effects including anaphylactic shock.
"I thought, well, if they make antivenom in horses, why can't I just use myself as a primate?" Friede said. He started working through the venom from all the deadly species he could get his hands on, such as cobras, taipans, black mambas and rattlesnakes.
"There is pain every time," he said.
'Proud'
For years, the scientists he contacted to take advantage of his immunity refused to bite.
Then in 2017, immunologist Jacob Glanville, who previously worked on universal vaccines, turned his attention towards antivenom.
Glanville told AFP he had been looking for "a clumsy snake researcher who'd been bit accidentally a couple times," when he came across a video of Friede taking brutal back-to-back snake bites.
When they first spoke, Glanville said he told Friede: "I know this is awkward, but I would love to get my hands on some of your blood."
"I've been waiting for this call for a long time," came the response, Glanville said.
The antivenom described in the Cell paper includes two antibodies from Friede's blood, as well as a drug called varespladib.
It offered mice full protection against 13 of the 19 snake species tested, and partial protection for the remaining six.
The researchers hope a future cocktail will cover far more snakes -- particularly vipers -- with further trials planned on dogs in Australia.
Timothy Jackson of the Australian Venom Research Unit praised the immunological research, but questioned whether a human needed to be involved, pointing to synthetically developed antibodies.
Glanville said the ultimate goal of his US-based firm Centivax was to develop a universal antivenom administered by something like an EpiPen, potentially produced in India to keep the costs down.
Friede said he was "proud" to have made a "small difference" in medical history.
Now working for Centivax, Friede stopped self-inflicting himself with venom in 2018 to save the firm from liability issues.
But he hopes to get bitten by snakes again in the future. "I do miss it," he said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Insider
7 days ago
- Gulf Insider
Early COVID-19 Vaccine Patent In China Raises New Questions For U.S. Investigators
A Chinese patent for a COVID-19 vaccine filed just weeks after the virus emerged in the United States is drawing fresh scrutiny from U.S. investigators examining the origins of the pandemic and potential efforts to conceal early information about the virus. The February 24, 2020, patent application – submitted by three Chinese entities affiliated with the People's Liberation Army – outlines a process for developing a 'COVID-19 protein vaccine.' The document, which predates the World Health Organization's declaration of a global pandemic, lists 11 inventors. Among them are two scientists affiliated with a neuroscience institute within the Chinese military – a detail that has puzzled U.S. officials, given that neurological symptoms of COVID-19 were not widely known or studied at the time. The participation of researchers from the Institute of Military Cognition and Brain Sciences – a division of the Academy of Military Sciences in Beijing – has raised particular concern among federal investigators. The institute, which has drawn attention from U.S. defense analysts in recent years, plays a role in the Chinese military's emerging focus on cognitive warfare – the strategic use of neuroscience in national defense, Just the News reports. 'Significantly, their published research provided limited, or no data of neuropathology observed in the experimental animals, or the neuroprotection afforded by the vaccine,' wrote Dr. Robert Kadlec, a former senior Health and Human Services official, in a 2023 report examining the origins of the pandemic. 'Institute of Military Cognition researchers' involvement in such studies suggest an interest in the vaccine's protection against SARS-CoV-2 early in the outbreak before evidence of its neurological effects were widely known.' Dr. Kadlec, who served in the Trump administration and played a central role in Operation Warp Speed, was among the first U.S. officials to question why neuroscientists were included in early Chinese vaccine development. His report, titled A Critical Review of COVID-19 Origins: Hidden in Plain Sight , was published last September. Other figures on Capitol Hill have voiced similar concerns. Representative Darin LaHood, Republican of Illinois and a member of the House Intelligence Committee, recently stated that the cover-up of COVID-19's early emergence in China should be understood in the context of Beijing's broader strategic ambitions. 'China has a plan to replace the United States, and they're working at it every single day,' Mr. LaHood said in a podcast interview this week. 'They want to beat us technologically, militarily, economically and diplomatically. And the sooner we wake up to that, the better.' '… And we've seen evidence of this through Huawei and what China… has done with Huawei, what they've done with TikTok, what they've done now with Deep Seek, what they did… in terms of lying and being deceitful with the Wuhan virus,' he continued. Possibly part of that effort: Chinese military strategists are actively developing new methods for using neurology to gain advantages on the battlefield, according to Elsa Kania, Adjunct Senior Fellow at the Center for New American Security. 'On the battlefield, attempts to undermine an adversary could include interfering with the adversary's capacity for cognition, whether through manipulation or out-right destruction, from disrupting the flow of data to exploiting ideology or emotion,' she wrote in January 2020 for U.S. National Defense University magazine, Prism, which focuses on 'emerging disruptive technologies.' -Just the News At the center of the February 2020 vaccine patent is Zhou Yusen, a senior military scientist at the State Key Laboratory of Pathogen and Biosecurity. Zhou, who previously collaborated with the Wuhan Institute of Virology on SARS and MERS vaccines, is among the 11 listed inventors. According to Senate researchers, Zhou died under unclear circumstances in the months following the outbreak. The presence of neuroscientists on the patent application – including Yan Li and Gencheng Han – has intensified questions about what Chinese scientists may have known about COVID-19's broader physiological effects in the earliest days of the outbreak. A separate scientific paper identifies both researchers as members of the Institute of Military Cognition and Brain Sciences. At the time the patent was filed, neurological symptoms of COVID-19 were not widely reported or understood by Western scientists. Subsequent studies have shown that COVID-19 can have long-lasting neurological effects. A 2022 study published in Nature found that survivors of COVID-19 faced elevated risks of conditions including strokes, memory disorders, migraines, and seizures in the months following infection. Researchers at Duke University reported neurocognitive impairments and sleep disturbances lasting up to three months in some patients. The earliest Chinese study documenting COVID-19's neurological symptoms was published in April 2020. According to the study, which was based on clinical data from Wuhan, patient monitoring was still underway five days before the vaccine patent was filed. The new questions about the early vaccine patent follow revelations this week that a Defense Intelligence Agency unit concluded in mid-2020 that COVID-19 was likely genetically engineered and leaked from a laboratory. That internal study, which described the virus's spike protein as a 'chimera,' was not included in official U.S. intelligence assessments. It was only released following Freedom of Information Act requests and is now part of the ongoing congressional investigation. The Defense Intelligence Agency analysis traced elements of the COVID-19 virus back to a decade-old scientific manuscript published by the Wuhan Institute of Virology, which has worked closely with the Chinese military on coronavirus research, according to the U.S. intelligence community. Taken together, these findings are intensifying scrutiny of early Chinese responses to the virus, as well as raising new questions about what information may have been known – and withheld – in the earliest stages of the global pandemic.
Daily Tribune
12-06-2025
- Daily Tribune
Writer first to die under Italy fast-track assisted suicide law
AFP | Rome A writer suffering from Parkinson's disease has become the first to die through medically assisted suicide under a fast-track regional law in Italy, campaigners said yesterday. Daniele Pieroni died at home on May 17, three months after the new legislation was passed by regional authorities in Tuscany, the pro-euthanasia Luca Coscioni Association said. The Italian Constitutional Court ruled in September 2019 that assisted suicide was allowed for patients in certain circumstances. But the national parliament has yet to adopt any legislation, which means that obtaining permission to die is difficult and can take years. In February, Tuscany -- ruled by the centre left -- became the first of Italy's 20 regions to set out its own rules streamlining and speeding up the request process. Prime Minister Giorgia Meloni's right-wing coalition is broadly against euthanasia and is challenging the Tuscan law in court. But any decision on that will come too late to affect Pieroni's choice. Born in 1961, the writer had been suffering from Parkinson's disease since 2008 and was forced to use a feeding tube for 21 hours a day, the Luca Coscioni Association said in a statement. 'The lethal drug was prepared at his home, which Daniele self-administered' in the presence of doctors and his family, the statement added. It has called on other regions in the Catholic-majority country to follow Tuscany's lead. 'Too many people continue to suffer or emigrate to die with dignity,' said the association. 'We invite all regions to act to guarantee freedom and respect for people's wishes.' Helping someone take their own life is technically illegal in Italy, punishable with between five and 12 years behind bars. But the Constitutional Court made an exception for those facing an incurable illness causing 'intolerable' physical or psychological suffering, where they are kept alive by life-support treatments but remain capable of making 'free and informed decisions'.
Daily Tribune
12-06-2025
- Daily Tribune
New T-Rex ancestor discovered in drawers of Mongolian institute
AFP | Paris Misidentified bones that languished in the drawers of a Mongolian institute for 50 years belong to a new species of tyrannosaur that rewrites the family history of the mighty T-Rex, scientists said yesterday. This slender ancestor of the massive Tyrannosauru s Rex was around four metres (13 feet) long and weighed three quarters of a tonne, according to a new study in the journal Nature. 'It would have been the size of a very large horse,' study co-author Darla Zelenitsky of Canada's University of Calgary told AFP. 1970s The fossils were first dug up in southeastern Mongolia in the early 1970s but at the time were identified as belonging to a different tyrannosaur, Alectrosaurus. For half a century, the fossils sat in the drawers at the Institute of Paleontology of the Mongolian Academy of Sciences in the capital Ulaanbaatar. Then PhD student Jared Voris, who was on a trip to Mongolia, started looking through the drawers and noticed something was wrong, Zelenitsky said. It turned out the fossils were well-preserved, partial skeletons of two different individuals of a completely new species. 'It is quite possible that discoveries like this are sitting in other museums that just have not been recognised,' Zelenitsky added. 'Messy' family history They named the new species Khankhuuluu mongoliensis, which roughly means the dragon prince of Mongolia because it is smaller than the 'king' T-Rex. Zelenitsky said the discovery 'helped us clarify a lot about the family history of the tyrannosaur group because it was really messy previously'. The T-Rex represented the end of the family line. It was the apex predator in North America until 66 million years ago, when an asteroid bigger than Mount Everest slammed into the Gulf of Mexico. Three quarters of life on Earth was wiped out, including all the dinosaurs that did not evolve into birds. Around 20 million years earlier, Khankhuuluu -- or another closely related family member -- is now believed to have migrated from Asia to North America using the land bridge that once connected Siberia and Alaska. North America This led to tyrannosaurs evolving across North America. Then one of these species is thought to have crossed back over to Asia, where two tyrannosaur subgroups emerged. One was much smaller, weighing under a tonne, and was nicknamed Pinocchio rex for its long snout. The other subgroup was huge and included behemoths like the Tarbosaurus, which was only a little smaller than the T-rex. One of the gigantic dinosaurs then left Asia again for North America, eventually giving rise to the T-Rex, which dominated for just two million years -- until the asteroid struck.
